Vivien Mak

642 total citations
11 papers, 384 citations indexed

About

Vivien Mak is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Vivien Mak has authored 11 papers receiving a total of 384 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Hematology, 4 papers in Genetics and 3 papers in Molecular Biology. Recurrent topics in Vivien Mak's work include Acute Myeloid Leukemia Research (3 papers), Retinoids in leukemia and cellular processes (2 papers) and Hemoglobinopathies and Related Disorders (2 papers). Vivien Mak is often cited by papers focused on Acute Myeloid Leukemia Research (3 papers), Retinoids in leukemia and cellular processes (2 papers) and Hemoglobinopathies and Related Disorders (2 papers). Vivien Mak collaborates with scholars based in China, Canada and Hong Kong. Vivien Mak's co-authors include Tamara Shenkier, Kerry J. Savage, Laurie H. Sehn, Randy D. Gascoyne, Diego Villa, Joseph M. Connors, Richard Klasa, Mukesh Chhanabhai, Sze‐Fai Yip and Bonnie Kho and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Vivien Mak

9 papers receiving 376 citations

Peers

Vivien Mak
Vishala T. Neppalli United States
Ahmed Ali Elsayed Japan
Marie-Hélène Delfau France
Machiko Tsukaguchi Japan
Francesco Moro Italy
Pedro Sánchez‐Godoy Spain
Cornelis G. Scheepstra Netherlands
Edgardo R. Parrilla Castellar United States
Chuan‐Cheng Wang Taiwan
F Teillet France
Vishala T. Neppalli United States
Vivien Mak
Citations per year, relative to Vivien Mak Vivien Mak (= 1×) peers Vishala T. Neppalli

Countries citing papers authored by Vivien Mak

Since Specialization
Citations

This map shows the geographic impact of Vivien Mak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vivien Mak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vivien Mak more than expected).

Fields of papers citing papers by Vivien Mak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vivien Mak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vivien Mak. The network helps show where Vivien Mak may publish in the future.

Co-authorship network of co-authors of Vivien Mak

This figure shows the co-authorship network connecting the top 25 collaborators of Vivien Mak. A scholar is included among the top collaborators of Vivien Mak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vivien Mak. Vivien Mak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
2.
Ling, Ryan Ruiyang, Bryan E‐Xin Tan, Vivien Mak, et al.. (2025). Concurrent Use of Kidney Replacement Therapy and Temporary Left Ventricular Assist Device in Cardiogenic Shock: A Systematic Review and Meta-Analysis. Blood Purification. 54(8). 497–512.
3.
Hwang, Yu‐Yan, Bonnie Kho, June S. M. Lau, et al.. (2022). Eltrombopag as frontline treatment of aplastic anaemia in routine practice: implications on cost and efficacy. Annals of Hematology. 101(6). 1163–1172. 1 indexed citations
4.
Mak, Vivien, et al.. (2020). Liver complications of haemoglobin H disease in adults. British Journal of Haematology. 192(1). 171–178. 5 indexed citations
5.
6.
7.
Gill, Harinder, Anskar Y.H. Leung, June S. M. Lau, et al.. (2015). Clinicopathologic features and prognostic indicators in Chinese patients with myelofibrosis. Hematology. 21(1). 10–18. 3 indexed citations
8.
Mak, Vivien, Mukesh Chhanabhai, Tamara Shenkier, et al.. (2013). Survival of Patients With Peripheral T-Cell Lymphoma After First Relapse or Progression: Spectrum of Disease and Rare Long-Term Survivors. Journal of Clinical Oncology. 31(16). 1970–1976. 286 indexed citations
9.
Au, W.Y., Eric Y. T. Chan, Gcf Chan, et al.. (2011). A synopsis of current haemophilia care in Hong Kong.. PubMed. 17(3). 189–94. 8 indexed citations
10.
Mak, Vivien, Joseph M. Connors, Richard Klasa, et al.. (2011). Survival of Peripheral T-Cell Lymphomas (PTCLs) Patients Following Relapse: Spectrum of Disease and Rare Long-Term Survivors. Blood. 118(21). 96–96. 4 indexed citations
11.
Fam, Adel G., Wedad Hanna, Vivien Mak, & Dalal Assaad. (1998). Fibroblastic rheumatism: clinical and histologic evolution of cutaneous manifestations.. PubMed. 25(11). 2261–6. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vishala T. Neppalli Breakdown of academic impact, for papers by Ahmed Ali Elsayed Breakdown of academic impact, for papers by Marie-Hélène Delfau Breakdown of academic impact, for papers by Machiko Tsukaguchi Breakdown of academic impact, for papers by Francesco Moro Breakdown of academic impact, for papers by Pedro Sánchez‐Godoy Breakdown of academic impact, for papers by Cornelis G. Scheepstra Breakdown of academic impact, for papers by Edgardo R. Parrilla Castellar Breakdown of academic impact, for papers by Chuan‐Cheng Wang Breakdown of academic impact, for papers by F Teillet
Rankless by CCL
2026